MORF NEWS: Johnson Fistel has Commenced an Investigation on Behalf of Morphic Holding Company Shareholders


SAN DIEGO, Dec. 19, 2023 (GLOBE NEWSWIRE) — Johnson Fistel, is investigating potential securities claims against Morphic Holding, Inc. (NASDAQ: MORF) on behalf of stockholders. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.

Morphic Holding, Inc, a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, and metabolic diseases, as well as fibrosis and cancer.

In September of 2023, the company released details of its 12-week treatment of severe ulcerative colitis. The results demonstrated that 25.7% of patients who received their treatment showed endoscopic improvement. Following this news, the stock plummeted 55%. Following this news, the company’s stock price dropped dramatically.


If you purchased securities and suffered significant losses on your investment, click here. Or for more information, contact Jim Baker at [email protected] or (619) 814-4471

There is no cost or obligation to you.  

What if I have relevant nonpublic information? Individuals with nonpublic information regarding the company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program. Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to thirty percent of any successful recovery made by the SEC. For more information, contact Jim Baker at (619) 814-4471 or [email protected].

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.

Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
[email protected] or [email protected] 


Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.